SEARCH

SEARCH BY CITATION

References

  • Arai, M., Kondoh, N., Imazeki, N., Hada, A., Hatsuse, K., Matsubara, O. & Yamamoto, M. (2009) The knockdown of endogenous replication factor C4 decreases the growth and enhances the chemosensitivity of hepatocellular carcinoma cells. Liver Int International, 29, 5562.
  • Bhojwani, D., Kang, H., Moskowitz, N.P., Min, D.J., Lee, H., Potter, J.W., Davidson, G., Willman, C.L., Borowitz, M.J., Belitskaya-Levy, I., Hunger, S.P., Raetz, E.A. & Carroll, W.L. (2006) Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children’s Oncology Group study. Blood, 108, 711717.
  • Ehrchen, J.M., Sunderkotter, C., Foell, D., Vogl, T. & Roth, J. (2009) The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. Journal of Leukocyte Biology, 86, 557566.
  • Fine, B.M., Stanulla, M., Schrappe, M., Ho, M., Viehmann, S., Harbott, J. & Boxer, L.M. (2004) Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia. Blood, 103, 10431049.
  • Hilden, J.M., Dinndorf, P.A., Meerbaum, S.O., Sather, H., Villaluna, D., Heerema, N.A., McGlennen, R., Smith, F.O., Woods, W.G., Salzer, W.L., Johnstone, H.S., Dreyer, Z. & Reaman, G.H. (2006) Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children’s Oncology Group. Blood, 108, 441451.
  • Holleman, A., Cheok, M.H., Den Boer, M.L., Yang, W., Veerman, A.J., Kazemier, K.M., Pei, D., Cheng, C., Pui, C.H., Relling, M.V., Janka- Schaub, G.E., Pieters, R. & Evans, W.E. (2004) Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. New England Journal of Medicine, 351, 533542.
  • Kadyrov, F.A., Genschel, J., Fang, Y., Penland, E., Edelman, W. & Modrich, P. (2009) A possible mechanism for exonuclease 1-independent eukaryotic mismatch repair. Proceedings of the National Academy of Sciences of the United States of America, 106, 84958500.
  • Klochendler-Yeivin, A., Muchardt, C. & Yaniv, M. (2002) SWI/SNF chromatin remodeling and cancer. Current Opinion in Genetics and Development, 12, 7379.
  • Leukert, N., Vogl, T., Strupat, K., Reichelt, R., Sorg, C. & Roth, J. (2006) Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity. Journal of Molecular Biology, 359, 961972.
  • Mahajan, S., Ghosh, S., Sudbeck, E.A., Zheng, Y., Downs, S., Hupke, M. & Uckun, F.M. (1999) Rational design and synthesis of a novel anti-leukaemic agent targeting Bruton’s tyrosine kinase (BTK), LFM-A13 [alpha-cyano-beta-hydroxy-beta-methyl-N-(2, 5-dibromophenyl)propenamide]. Journal of Biological Chemistry, 274, 95879599.
  • Matloub, Y., Lindemulder, S., Gaynon, P.S., Sather, H., La, M., Broxson, E., Yanofsky, R., Hutchinson, R., Heerema, N.A., Nachman, J., Blake, M., Wells, L.M., Sorrell, A.D., Masterson, M., Kelleher, J.F. & Stork, L.C. (2006) Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children’s Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children’s Oncology Group. Blood, 108, 11651173.
  • Morrissey, P., Conlon, P., Charrier, K., Braddy, S., Alpert, A., Williams, D., Namen, A.E. & Mochizuki, D. (1991) Administration of IL-7 to normal mice stimulates B-lymphopoiesis and peripheral lymphadenopathy. Journal of Immunology, 147, 561568.
  • Nakayama, J., Yamamoto, M., Hayashi, K., Satoh, H., Bundo, K., Kubo, M., Goitsuka, R., Farrar, M.A. & Kitamura, D. (2009) BLNK suppresses pre-B cell leukemogenesis through inhibition of JAK3. Blood 113, 14831492.
  • Narla, R.K., Dong, Y., D’ Cruz, O.J., Navara, C. & Uckun, F.M. (2000) Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent. Clinical Cancer Research, 6, 15461556.
  • Nemeth, J., Stein, I., Haag, D., Riehl, A., Longreich, T., Horwitz, E., Breuhahn, K., Gebhardt, C., Schirmacher, P., Hahn, M., Ben-Neriah, Y., Pikarsky, E., Angel, P. & Hess, J. (2009) S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Hepatology, 50, 12511262.
  • Nie, Z., Yan, Z., Chen, E.H., Sechi, S., Ling, C., Zhou, S., Xue, Y., Yang, D., Murray, D., Kanakubo, E., Cleary, M.L. & Wang, W. (2003) Novel SWI/SNF chromatin-remodeling complexes contain a mixed-lineage leukemia chromosomal translocation partner. Molecular and Cellular Biology, 23, 29422952.
  • Park, J.H., Park, E.J., Hur, S.K., Kim, S. & Kwon, J. (2009) Mammalian SWI/SNF chromatin remodeling complexes are required to prevent apoptosis after DNA damage. DNA Repair, 8, 2939.
  • Reaman, G.H., Sposto, R., Sensel, M.G., Lange, B.J., Feusner, J.H., Heerema, N.A., Leonard, M., Holmes, E.J., Sather, H., Pendergrass, T.W., Johnstone, H.S., O’ Brien, R.T., Steinherz, P.G., Zeltzer, P.M., Gaynon, P.S., Trigg, M.E. & Uckun, F.M. (1999) Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia on two consecutive trials of the Children’s Cancer Group. Journal of Clinical Oncology, 17, 445455.
  • Redner, R.L., Wang, J. & Liu, J.M. (1999) Chromatin remodeling and leukemia: new therapeutic paradigms. Blood, 94, 417428.
  • Rhodes, D.R., Kalyana-Sundaram, S., Mahavisno, V., Varambally, R., Yu, J., Briggs, B.B., Barrette, T.R., Anstet, M.J., Kincead-Beal, C., Kulkarni, P., Varambally, S., Ghosh, D. & Chinnaiyan, A.M. (2007) Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia, 9, 166180.
  • Ross, M.E., Zhou, X., Song, G., Shurtleff, S.A., Girtman, K., Williams, W.K., Liu, H.C., Mahfouz, R., Raimondi, S.C., Lenny, N., Patel, A. & Downing, J.R. (2003). Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood. 102, 29512959.
  • Rozenblatt-Rosen, O., Rozovskaia, T., Burakov, D., Sedkov, Y., Tillib, S., Blechman, J., Nakamura, T., Croce, C., Mazo, A. & Canaani, E. (1998) The C-terminal SET domains of ALL-1 and trithorax interact with the INI1 and SNR1 proteins, components of the SWI/SNF complex. Proceedings of the National Academy of Sciences of the United States of America, 95, 41524157.
  • Seibel, N.L., Steinherz, P.G., Sather, H.N., Nachman, J.B., DeLaat, C., Ettinger, L.J., Freyer, D.R., Mattano, L.A., Hastings, C.A., Rubin, C.M., Bertolone, K., Franklin, J.L., Heerema, N.A., Mitchell, T.L., Pyesmany, A.F., La, M.K., Edens, C. & Gaynon, P.S. (2008) Early postinduction intensification therapy improves survival for children and adolescents with high risk acute lymphoblastic leukemia: a report from the Chilren’s Oncology Group. Blood, 111, 25482555.
  • Sudbeck, E.A., Liu, X.P., Narla, R.K., Mahajan, S., Ghosh, S., Mao, C. & Uckun, F.M. (1999) Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukaemic agents. Clinical Cancer Research, 5, 15691582.
  • Touw, I., Delwel, R., Bolhuis, R., Van Zanen, G. & Lowenberg, B. (1985) Common and pre-B acute lymphoblastic leukemia cells express interleukin 2 receptors, and interleukin 2 stimulates in vitro colony formation. Blood, 66, 556561.
  • Tsai, L.H., White, L., Raines, E., Ross, R., Smith, R.G., Cushley, W. & Ozanne, B. (1994) Expression of platelet-derived growth factor and its receptors by two pre-B acute lymphocytic leukemia cell lines. Blood, 83, 5155.
  • Tsutsumi, S., Taketani, T., Nishimura, K., Ge, X., Taki, T., Sugita, K., Ishii, E., Hanada, R., Ohki, M., Aburatani, H. & Hayashi, Y. (2003) Two distinct gene expression signatures in pediatric acute lymphoblastic leukemia with MLL rearrangements. Cancer Research, 63, 48824887.
  • Uckun, F.M., Myers, D.E., Fauci, A.S., Chandan-Langlie, M. & Ambrus, J.L. (1989) Leukaemic B-cell precursors constitutively express functional receptors for human interleukin-1. Blood 74:761776
  • Uckun, F.M., Dibirdik, I., Smith, R., Tuel-Ahlgren, L., Chandan-Langlie, M., Schieven, G.L., Waddick, K.G., Hanson, M. & Ledbetter, J.A. (1991) Interleukin 7 receptor ligation stimulates tyrosine phosphorylation, inositol phospholipid turnover, and clonal proliferation of human B-cell precursors. Proceedings of the National Academy of Sciences of the United States of America, 88, 35893593.
  • Van der Plas, D.C., Smiers, F., Pouwels, K., Hoefsloot, L.H., Lowenberg, B. & Touw, I.P. (1996) Interleukin 7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain. Leukemia, 10, 13171325.
  • Wang, W., Xue, Y., Zhou, S., Kuo, A., Cairns, B.R. & Crabtree, G.R. (1996) Diversity and specialization of mammalian SWI/SNF complexes. Genes & Development, 10, 21172130.
  • Yeoh, E.J., Ross, M.E., Shurtleff, S.A., Williams, W.K., Patel, D., Mahfouz, R., Behm, F.G., Raimondi, S.C., Relling, M.V., Patel, A., Cheng, C., Campana, D., Wilkins, D., Zhou, X., Li, J., Liu, H., Pui, C.H., Evans, W.E., Naeve, C., Wong, L. & Downing, J.R. (2002) Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell, 1, 133143.